Denkert C - Search Results

1

Expression of classical NF-kappaB pathway effectors in human ovarian carcinoma.

Darb-Esfahani S, Sinn BV, Weichert W, Budczies J, Lehmann A, Noske A, Buckendahl AC, Müller BM, Sehouli J, Koensgen D, Györffy B, Dietel M, Denkert C. Darb-Esfahani S, et al. Among authors: denkert c. Histopathology. 2010 May;56(6):727-39. doi: 10.1111/j.1365-2559.2010.03544.x. Histopathology. 2010. PMID: 20546338

2

Interleukin-10 in serous ovarian carcinoma cell lines.

Berger S, Siegert A, Denkert C, Köbel M, Hauptmann S. Berger S, et al. Among authors: denkert c. Cancer Immunol Immunother. 2001 Aug;50(6):328-33. doi: 10.1007/s002620100196. Cancer Immunol Immunother. 2001. PMID: 11570587 Free PMC article.

3

Expression of cyclooxygenase 2 is an independent prognostic factor in human ovarian carcinoma.

Denkert C, Köbel M, Pest S, Koch I, Berger S, Schwabe M, Siegert A, Reles A, Klosterhalfen B, Hauptmann S. Denkert C, et al. Am J Pathol. 2002 Mar;160(3):893-903. doi: 10.1016/S0002-9440(10)64912-7. Am J Pathol. 2002. PMID: 11891188 Free PMC article.

4

Genetic alterations in epithelial ovarian tumors analyzed by comparative genomic hybridization.

Hauptmann S, Denkert C, Koch I, Petersen S, Schlüns K, Reles A, Dietel M, Petersen I. Hauptmann S, et al. Among authors: denkert c. Hum Pathol. 2002 Jun;33(6):632-41. doi: 10.1053/hupa.2002.124913. Hum Pathol. 2002. PMID: 12152163

5

Expression of mitogen-activated protein kinase phosphatase-1 (MKP-1) in primary human ovarian carcinoma.

Denkert C, Schmitt WD, Berger S, Reles A, Pest S, Siegert A, Lichtenegger W, Dietel M, Hauptmann S. Denkert C, et al. Int J Cancer. 2002 Dec 10;102(5):507-13. doi: 10.1002/ijc.10746. Int J Cancer. 2002. PMID: 12432554

6

CD24 is an independent prognostic marker of survival in nonsmall cell lung cancer patients.

Kristiansen G, Schlüns K, Yongwei Y, Denkert C, Dietel M, Petersen I. Kristiansen G, et al. Among authors: denkert c. Br J Cancer. 2003 Jan 27;88(2):231-6. doi: 10.1038/sj.bjc.6600702. Br J Cancer. 2003. PMID: 12610508 Free PMC article.

7

Cytokine-suppressive anti-inflammatory drugs (CSAIDs) inhibit invasion and MMP-1 production of ovarian carcinoma cells.

Denkert C, Koch I, Berger S, Köbel M, Siegert A, Hauptmann S. Denkert C, et al. Cancer Lett. 2003 May 30;195(1):101-9. doi: 10.1016/s0304-3835(03)00052-1. Cancer Lett. 2003. PMID: 12767518

8

Elevated expression of cyclooxygenase-2 is a negative prognostic factor for disease free survival and overall survival in patients with breast carcinoma.

Denkert C, Winzer KJ, Müller BM, Weichert W, Pest S, Köbel M, Kristiansen G, Reles A, Siegert A, Guski H, Hauptmann S. Denkert C, et al. Cancer. 2003 Jun 15;97(12):2978-87. doi: 10.1002/cncr.11437. Cancer. 2003. PMID: 12784332 Free article.

9

Protein kinase C isoform expression in ovarian carcinoma correlates with indicators of poor prognosis.

Weichert W, Gekeler V, Denkert C, Dietel M, Hauptmann S. Weichert W, et al. Among authors: denkert c. Int J Oncol. 2003 Sep;23(3):633-9. Int J Oncol. 2003. PMID: 12888898

10

CD24 expression is a new prognostic marker in breast cancer.

Kristiansen G, Winzer KJ, Mayordomo E, Bellach J, Schlüns K, Denkert C, Dahl E, Pilarsky C, Altevogt P, Guski H, Dietel M. Kristiansen G, et al. Among authors: denkert c. Clin Cancer Res. 2003 Oct 15;9(13):4906-13. Clin Cancer Res. 2003. PMID: 14581365

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

489 results

Search Page

Filters